Postpartum hemorrhaging is the world's leading cause of death for women during and after childbirth, and the third-leading cause in the United States alone. Many doctors in developing countries have turned to the drug misoprostol ...
Dec 3, 2018
0
44
For women undergoing first-trimester induced abortion (IA), short-term adverse events are more likely among those prescribed mifepristone-misoprostol than procedural IA, according to a study published online Jan. 3 in the ...
Jan 3, 2023
0
7
A study of clinics' and primary care doctors' means of dispensing abortion medications during the pandemic may offer clinicians guidance for doing so in a post-Roe world.
Jul 18, 2022
0
26
Researchers from Brigham and Women's Hospital have found that administering the medication combination of mifepristone and misoprostol as early as possible can be done safely and can also help a patient determine whether ...
Apr 7, 2022
0
2
A pretreatment medication for women who suffer miscarriages—called mifepristone—is not only more clinically effective when combined with the standard of care drug, but also more cost effective, according to researchers ...
Apr 2, 2020
0
5
Common in hospitals and nursing homes, Clostridioides difficile infection (CDI) is a major health threat, particularly for older patients. According to a 2015 study by the Centers for Disease Control and Prevention, in the ...
Sep 27, 2019
1
1
A combination of the drugs mifepristone and misoprostol can help bring closure to some women and their families suffering from miscarriage, and reduces the need for surgical intervention to complete the painful miscarriage ...
Jun 6, 2018
0
4
Researchers from the University of Liverpool with colleagues from Gynuity Health Care in New York and the Government Medial College, Nagpur, India, have published a major study of two different types of labour induction methods ...
Jun 29, 2017
0
2
People who took the drug misoprostol for stomach ulcers along with non-steroidal anti-inflammatory (NSAID) drugs had a significantly lower risk of serious cardiovascular events, stroke and kidney failure than those who took ...
Mar 8, 2017
0
1
(HealthDay)—For women in the third stage of labor, misoprostol administered with routine oxytocin does not reduce the rate of postpartum hemorrhage, according to a study published online Sept. 5 in Obstetrics & Gynecology.
Sep 20, 2016
0
2
